3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE

3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
Generic 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
Type
Formula C18H22N6O3S
Weight Average: 402.471
Monoisotopic: 402.14740929
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE

Innovators Monograph

You find simplified version here 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=447655
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444719
https://www.chemspider.com/Chemical-Structure.394686.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=5550
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL123368
https://zinc.docking.org/substances/ZINC000020149014
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/N76
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

3,6,9,12,15-PENTAOXATRICOSAN-1-OL
(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID
2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID
NAM NAPTHYLAMINOALANINE
(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE
4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID
6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID
7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID
Haptoglobin blood test
PTEN Genetic Test
Therapeutic drug levels
Urinalysis
Myelodysplastic syndrome
Renal perfusion scintiscan
VDRL test
Scleredema diabeticorum
Haptoglobin (HP) Test
Coccidioides complement fixation
Noncompensatory Sinus tachycardia
Arterial Thromboembolism
Extracorporeal Clotting During Hemodialysis
Hypotension
Vancomycin-resistant Enterococcus faecium infection
Stiff Shoulder
Acute Pulmonary Edema
Postoperative treatment
Polycythemia Vera (PV)
Bone Mineral Density